Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sey-En Lin

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Biomedicines|March 28, 2024
Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular CarcinomaHeng-Yuan Hsu, Jui-Hsiang Tang, Song-Fong Huang, et al.
Plos One|December 31, 2013
Distinct clinical outcomes of non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) mutations treated with EGFR tyrosine kinase inhibitors: non-responders versus respondersShih-Hsin Hsiao, H Eugene Liu, Hsin-Lun Lee, et al.
Cell Death & Disease|January 3, 2026
SOX4-STAT6-MTHFD2 axis drives hepatocellular carcinoma progression and treatment resistanceChia-Lung Tsai, Ming-Chin Yu, Cheng-Lung Hsu, et al.
Oncology Letters|February 2, 2018
Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinomaChao-Wei Lee, Sey-En Lin, Hsin-I Tsai, et al.
Journal of Personalized Medicine|April 23, 2022
Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular CarcinomaChun-Wei Huang, Tsung-Han Wu, Heng-Yuan Hsu, et al.
Cancers|December 4, 2020
Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric EpendymomasMuh-Lii Liang, Chun-Han Chen, Yun-Ru Liu, et al.
Oncogene|May 15, 2020
SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivoChi-Neu Tsai, Shu-Chuan Yu, Chao-Wei Lee, et al.
Cancer Research|April 7, 2017
Expression of Neuroendocrine Factor VGF in Lung Cancer Cells Confers Resistance to EGFR Kinase Inhibitors and Triggers Epithelial-to-Mesenchymal TransitionWen Hwang, Yu-Fan Chiu, Ming-Han Kuo, et al.
Molecular and Clinical Oncology|March 21, 2014
Histological subtype and smoking status, but not gender, are associated with <i>epidermal growth factor receptor</i> mutations in non-small-cell lung cancerShih-Hsin Hsiao, Sey-En Lin, Yu-Ting Chou, et al.
Cancer Research|August 21, 2020
Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer DisseminationMing-Han Kuo, An-Chun Lee, Shih-Hsin Hsiao, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Biomedicines|March 28, 2024
Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular CarcinomaHeng-Yuan Hsu, Jui-Hsiang Tang, Song-Fong Huang, et al.
Plos One|December 31, 2013
Distinct clinical outcomes of non-small cell lung cancer patients with epidermal growth factor receptor (EGFR) mutations treated with EGFR tyrosine kinase inhibitors: non-responders versus respondersShih-Hsin Hsiao, H Eugene Liu, Hsin-Lun Lee, et al.
Cell Death & Disease|January 3, 2026
SOX4-STAT6-MTHFD2 axis drives hepatocellular carcinoma progression and treatment resistanceChia-Lung Tsai, Ming-Chin Yu, Cheng-Lung Hsu, et al.
Oncology Letters|February 2, 2018
Cadherin 17 is related to recurrence and poor prognosis of cytokeratin 19-positive hepatocellular carcinomaChao-Wei Lee, Sey-En Lin, Hsin-I Tsai, et al.
Journal of Personalized Medicine|April 23, 2022
Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular CarcinomaChun-Wei Huang, Tsung-Han Wu, Heng-Yuan Hsu, et al.
Cancers|December 4, 2020
Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric EpendymomasMuh-Lii Liang, Chun-Han Chen, Yun-Ru Liu, et al.
Oncogene|May 15, 2020
SOX4 activates CXCL12 in hepatocellular carcinoma cells to modulate endothelial cell migration and angiogenesis in vivoChi-Neu Tsai, Shu-Chuan Yu, Chao-Wei Lee, et al.
Cancer Research|April 7, 2017
Expression of Neuroendocrine Factor VGF in Lung Cancer Cells Confers Resistance to EGFR Kinase Inhibitors and Triggers Epithelial-to-Mesenchymal TransitionWen Hwang, Yu-Fan Chiu, Ming-Han Kuo, et al.
Molecular and Clinical Oncology|March 21, 2014
Histological subtype and smoking status, but not gender, are associated with <i>epidermal growth factor receptor</i> mutations in non-small-cell lung cancerShih-Hsin Hsiao, Sey-En Lin, Yu-Ting Chou, et al.
Cancer Research|August 21, 2020
Cross-talk between SOX2 and TGFβ Signaling Regulates EGFR-TKI Tolerance and Lung Cancer DisseminationMing-Han Kuo, An-Chun Lee, Shih-Hsin Hsiao, et al.
Pageof 5